Bobak Jack Mortazavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bobak Jack Mortazavi has a total of 375 co-authors. Here are the top co-authors by number of shared publications:
- Harlan M. Krumholz
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA
26 shared publications - Rohan Khera
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, USA
18 shared publications - Roozbeh Jafari
Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, MA, USA
10 shared publications - Akshay Khunte
Yale University
8 shared publications Chenxi Huang
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA
8 shared publications- Wade L. Schulz
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT
8 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Elsevier in American Journal of Preventive Cardiology
Impact of Optional Variables on PREVENT Risk Estimates and Clinical Risk Classification
- 14 November 2026
- Published by Elsevier in American Journal of Preventive Cardiology
Open AccessImpact of Optional Variables on PREVENT Risk Estimates and Clinical Risk Classification
- 14 April 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 215, 106387
Decision support systems (DSS) for predicting hypertensive events using real-world telemonitoring data
- 14 April 2026
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 215, 106387
Decision support systems (DSS) for predicting hypertensive events using real-world telemonitoring data
- Open Access
- 1 March 2026
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. ume 19, 1-11
Modeling In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention with Acute Myocardial Infarction Complicated by Cardiogenic Shock Receiving Mechanical Circulatory Support
Introduction: Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is a heterogeneous clinical syndrome associated with substantial morbidity and mortality. We developed a machine learning-based mortality model to identify features and patient subgroups associated with the largest change in mortality risk when evaluating treatment with Impella devices or intra-aortic Balloon Pump (IABP). Methods: Our cohort comprised 369 sites and 15,796 patient visits to the cardiac catheterization laboratory from the National Cardiovascular Data Registry. We developed XGBoost decision tree models to model mortality with and without treatment variable included (Impella or IABP). Results: The estimated population mean excess mortality effect of treatment with Impella devices vs IABP was 10.4 ± 0.8%. However, we identified clinical subgroups of 282 patients for whom a decreased risk of mortality was associated with use of Impella as compared with IABP. Those patients were on average younger, presented with higher systolic blood pressure, higher rate of salvage percutaneous coronary intervention, higher initial creatinine, and lower hemoglobin. Discussion: While Impella devices were associated with higher mortality risk overall, certain clinical profiles were associated with lower risk, illustrating heterogeneity of treatment effects.
- 1 March 2026
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. ume 19, 1-11
Open AccessModeling In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention with Acute Myocardial Infarction Complicated by Cardiogenic Shock Receiving Mechanical Circulatory Support
Introduction: Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is a heterogeneous clinical syndrome associated with substantial morbidity and mortality. We developed a machine learning-based mortality model to identify features and patient subgroups associated with the largest change in mortality risk when evaluating treatment with Impella devices or intra-aortic Balloon Pump (IABP). Methods: Our cohort comprised 369 sites and 15,796 patient visits to the cardiac catheterization laboratory from the National Cardiovascular Data Registry. We developed XGBoost decision tree models to model mortality with and without treatment variable included (Impella or IABP). Results: The estimated population mean excess mortality effect of treatment with Impella devices vs IABP was 10.4 ± 0.8%. However, we identified clinical subgroups of 282 patients for whom a decreased risk of mortality was associated with use of Impella as compared with IABP. Those patients were on average younger, presented with higher systolic blood pressure, higher rate of salvage percutaneous coronary intervention, higher initial creatinine, and lower hemoglobin. Discussion: While Impella devices were associated with higher mortality risk overall, certain clinical profiles were associated with lower risk, illustrating heterogeneity of treatment effects.
- Open Access
- 18 February 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (3)
Artificial intelligence-based automated interpretation of images of electrocardiograms: development and multinational validation of ECG-GPT
Aims: Timely, accurate assessment of electrocardiograms (ECGs) is crucial for diagnosing, triaging, and managing patients. However, this often relies on expert interpretation, a major bottleneck in low-resource settings. We developed and validated ECG-GPT, a format-independent vision encoder–decoder model that generates expert-level interpretations from 12-lead ECG images. Methods and results: We developed ECG-GPT using 12-lead ECGs and their corresponding diagnosis statements performed at a large US health system between 2000 and 2022. Using structured clinical assessment, semantic similarity, and conventional metrics, we validated ECG-GPT across seven distinct health settings, including three large and diverse US health systems, ECGs from Minas Gerais, Brazil, the UK Biobank, the Germany-based PTB-XL dataset, and a community hospital in Missouri. In total, 2.9 million ECGs were used for model development, and 4.1 million ECGs for validation. The model performed well in clinical assessment across 26 extracted labels, with diagnostic accuracy ranging from 0.93 to 0.99. For rhythm abnormalities, including atrial fibrillation, sinus tachycardia, sinus bradycardia, premature atrial contractions, and premature ventricular contractions, AUROCs ranged from 0.80 to 0.95. For conduction abnormalities, including left bundle branch block, right bundle branch block, first degree atrioventricular block, left anterior fascicular block, and left posterior fascicular block, AUROCs ranged from 0.88 to 0.96. ECG-GPT identified the full context of diagnosis statements with allied conditions with a median pairwise similarity of 0.90, significantly greater than baseline (P < 0.001). Results were comparable across external validation sites. Conclusion: We developed and validated a vision encoder-decoder model that generates expert-level interpretations from ECG images, a scalable strategy for accessible automated ECG analysis.
- 18 February 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (3)
Open AccessArtificial intelligence-based automated interpretation of images of electrocardiograms: development and multinational validation of ECG-GPT
Aims: Timely, accurate assessment of electrocardiograms (ECGs) is crucial for diagnosing, triaging, and managing patients. However, this often relies on expert interpretation, a major bottleneck in low-resource settings. We developed and validated ECG-GPT, a format-independent vision encoder–decoder model that generates expert-level interpretations from 12-lead ECG images. Methods and results: We developed ECG-GPT using 12-lead ECGs and their corresponding diagnosis statements performed at a large US health system between 2000 and 2022. Using structured clinical assessment, semantic similarity, and conventional metrics, we validated ECG-GPT across seven distinct health settings, including three large and diverse US health systems, ECGs from Minas Gerais, Brazil, the UK Biobank, the Germany-based PTB-XL dataset, and a community hospital in Missouri. In total, 2.9 million ECGs were used for model development, and 4.1 million ECGs for validation. The model performed well in clinical assessment across 26 extracted labels, with diagnostic accuracy ranging from 0.93 to 0.99. For rhythm abnormalities, including atrial fibrillation, sinus tachycardia, sinus bradycardia, premature atrial contractions, and premature ventricular contractions, AUROCs ranged from 0.80 to 0.95. For conduction abnormalities, including left bundle branch block, right bundle branch block, first degree atrioventricular block, left anterior fascicular block, and left posterior fascicular block, AUROCs ranged from 0.88 to 0.96. ECG-GPT identified the full context of diagnosis statements with allied conditions with a median pairwise similarity of 0.90, significantly greater than baseline (P < 0.001). Results were comparable across external validation sites. Conclusion: We developed and validated a vision encoder-decoder model that generates expert-level interpretations from ECG images, a scalable strategy for accessible automated ECG analysis.
- Open Access
- 20 January 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (2) , 102540
Using Machine Learning to Predict Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion
- 20 January 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (2) , 102540
Open AccessUsing Machine Learning to Predict Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion
- 8 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (12) , 8588-8590
Guest Editorial: Precision Health: AI Tailored to Individuals
- 8 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (12) , 8588-8590
Guest Editorial: Precision Health: AI Tailored to Individuals
- Open Access
- 1 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Open Journal of Engineering in Medicine and Biology
- Vol. 7, 14-19
ArterialNet: Reconstructing Arterial Blood Pressure Waveform With Wearable Pulsatile Signals, a Cohort-Aware Approach
Goal: Continuous arterial blood pressure (ABP) waveform is invasive but essential for hemodynamic monitoring. Current non-invasive techniques reconstruct ABP waveforms with pulsatile signals but derived inaccurate systolic and diastolic blood pressure (SBP/DBP) and were sensitive to individual variability. Methods: ArterialNet integrates generalized pulsatile-to-ABP signal translation and personalized feature extraction using hybrid loss functions and regularizations. Results: ArterialNet achieved a root mean square error (RMSE) of 5.41 ± 1.35 mmHg on MIMIC-III, achieving 58% lower standard deviation than existing signal translation techniques. ArterialNet also reconstructed ABP with RMSE of 7.99 ± 1.91 mmHg in remote health scenario. Conclusion: ArterialNet achieved superior performance in ABP reconstruction and SBP/DBP estimations with significantly reduced subject variance, demonstrating its potential in remote health settings. We also ablated ArterialNet's architecture to investigate contributions of each component and evaluated ArterialNet's translational impact and robustness by conducting a series of ablations on data quality and availability.
- 1 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Open Journal of Engineering in Medicine and Biology
- Vol. 7, 14-19
Open AccessArterialNet: Reconstructing Arterial Blood Pressure Waveform With Wearable Pulsatile Signals, a Cohort-Aware Approach
Goal: Continuous arterial blood pressure (ABP) waveform is invasive but essential for hemodynamic monitoring. Current non-invasive techniques reconstruct ABP waveforms with pulsatile signals but derived inaccurate systolic and diastolic blood pressure (SBP/DBP) and were sensitive to individual variability. Methods: ArterialNet integrates generalized pulsatile-to-ABP signal translation and personalized feature extraction using hybrid loss functions and regularizations. Results: ArterialNet achieved a root mean square error (RMSE) of 5.41 ± 1.35 mmHg on MIMIC-III, achieving 58% lower standard deviation than existing signal translation techniques. ArterialNet also reconstructed ABP with RMSE of 7.99 ± 1.91 mmHg in remote health scenario. Conclusion: ArterialNet achieved superior performance in ABP reconstruction and SBP/DBP estimations with significantly reduced subject variance, demonstrating its potential in remote health settings. We also ablated ArterialNet's architecture to investigate contributions of each component and evaluated ArterialNet's translational impact and robustness by conducting a series of ablations on data quality and availability.
- Open Access
Modeling In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention with Acute Myocardial Infarction Complicated by Cardiogenic Shock Receiving Mechanical Circulatory Support
Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is a heterogeneous clinical syndrome associated with substantial morbidity and mortality. We developed a machine learning-based mortality model to identify features and patient subgroups associated with the largest change in mortality risk when evaluating treatment with Impella devices or intra-aortic Balloon Pump (IABP). Our cohort comprised 369 sites and 15,796 patient visits to the cardiac catheterization laboratory from the National Cardiovascular Data Registry. The estimated population mean excess mortality effect of treatment with Impella devices vs IABP was 10.4 ± 0.8%. However, we identified clinical subgroups of 282 patients for whom a decreased risk of mortality was associated with use of Impella as compared with IABP. Those patients were on average younger, presented with higher systolic blood pressure, higher rate of salvage percutaneous coronary intervention, higher initial creatinine, and lower hemoglobin. While Impella devices were associated with higher mortality risk overall, certain clinical profiles were associated with lower risk, illustrating heterogeneity of treatment effects.
Open AccessModeling In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention with Acute Myocardial Infarction Complicated by Cardiogenic Shock Receiving Mechanical Circulatory Support
Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is a heterogeneous clinical syndrome associated with substantial morbidity and mortality. We developed a machine learning-based mortality model to identify features and patient subgroups associated with the largest change in mortality risk when evaluating treatment with Impella devices or intra-aortic Balloon Pump (IABP). Our cohort comprised 369 sites and 15,796 patient visits to the cardiac catheterization laboratory from the National Cardiovascular Data Registry. The estimated population mean excess mortality effect of treatment with Impella devices vs IABP was 10.4 ± 0.8%. However, we identified clinical subgroups of 282 patients for whom a decreased risk of mortality was associated with use of Impella as compared with IABP. Those patients were on average younger, presented with higher systolic blood pressure, higher rate of salvage percutaneous coronary intervention, higher initial creatinine, and lower hemoglobin. While Impella devices were associated with higher mortality risk overall, certain clinical profiles were associated with lower risk, illustrating heterogeneity of treatment effects.
- 5 September 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (9) , 6128-6131
Guest Editorial: Transforming Healthcare and Medicine With Biomedical Informatics and Emerging AI
- 5 September 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (9) , 6128-6131
Guest Editorial: Transforming Healthcare and Medicine With Biomedical Informatics and Emerging AI